Zone 2's Mitochondria Claim Rests on Elite Athletes, Not You
A 2025 review traced the popular Zone 2 advice to athletes training 15 to 20 hours a week, not to trials in ordinary people.
Evidence rating for the proposition “Aerobic exercise training raises measured VO2max in previously inactive or healthy adults”: Established
Its evidence base is thinner than the advice suggests. A narrative review traced the popular claim that Zone 2 training builds mitochondrial and fatty-acid oxidative capacity back to its actual source: observational data from elite endurance athletes already training 15 to 20 hours a week, not controlled trials in ordinary people. The review argues that association does not automatically transfer to someone training 3 to 4 hours a week, and that current evidence does not support Zone 2 as the optimal intensity for mitochondrial or fatty-acid capacity in that group. It argues higher intensities matter more for cardiometabolic benefit at lower training volumes.
Does Zone 2 training actually improve mitochondria in ordinary people?
The review's central argument is about evidence provenance, not about disputing that elite endurance athletes have impressive mitochondrial capacity. It's that the observational link, athletes who do enormous volumes of low-intensity training also have high mitochondrial capacity, was pulled out of its original context (extremely high training volumes, an athlete population selected in part for that same physiology) and repackaged as a specific-intensity recommendation for anyone, at any training volume.
That's a real logical gap worth naming directly. An association observed in elite athletes training 15-20 hours a week doesn't automatically transfer to someone training 3-4 hours a week choosing which intensity to prioritize within that much smaller volume.
1 study
- The review found that popular Zone 2 training recommendations for the general population are largely extrapolated from observational data in elite endurance athletes, and concluded that current evidence does not support Zone 2 as the optimal intensity for improving mitochondrial or fatty acid oxidative capacity. It further concluded that prioritizing higher exercise intensities above Zone 2 is more likely to maximize cardiometabolic health benefits, particularly for people training at lower overall volumes.
A review, not a new trial, and worth reading as such
This is a narrative review, a critical synthesis and argument built on existing published evidence, not a new controlled trial generating fresh data. Its value is in the argument it makes about how the existing evidence has been interpreted and marketed, not in new experimental results. Readers should weigh it as a pointed critique of the current evidence base, not as a standalone trial finding.
The review's own framing is worth taking at face value: it explicitly challenges the broad endorsement of Zone 2 training for the general public, arguing that doing so contradicts a separate, substantial body of evidence supporting higher-intensity exercise for mitochondrial capacity and cardiometabolic health, especially when training time is limited.
This is one narrative review representing one research group's reading of the existing literature, not a systematic review or meta-analysis with a formal quantitative synthesis. Its conclusions are a real, evidence-based argument worth taking seriously, not a settled consensus position.
How this differs from the site's existing HIIT-vs-steady-state coverage
The existing HIIT vs. steady-state cardio for VO2max piece compares the two training approaches on VO2max improvement specifically. This piece is narrower and more pointed: a direct critique of the evidentiary basis for the Zone 2 training recommendation itself, specifically for mitochondrial and fatty acid oxidative capacity, a related but distinct outcome from VO2max improvement.
Common questions
Is Zone 2 training proven to improve mitochondrial capacity in the general population?
A 2025 narrative review concluded the evidence does not support this. The Zone 2 recommendation is largely drawn from observational data in elite endurance athletes rather than controlled evidence specifically testing the general population.
Where did the popular Zone 2 training advice come from?
According to this review, it stems from observational data showing elite endurance athletes, who train at very high volumes, have high mitochondrial and fatty acid oxidative capacity, an association that was then generalized into a specific-intensity recommendation for the broader public.
Does this mean high-intensity training is better than Zone 2 for everyone?
The review argues that prioritizing intensities above Zone 2 is more likely to maximize cardiometabolic health benefits, particularly for people training at lower overall volumes, which describes most non-athletes. It is one review's conclusion, not a universal prescription.
Is this a new clinical trial or a review of existing evidence?
It's a narrative review, a critical synthesis of existing published evidence and argument about how that evidence has been interpreted, not a new controlled trial generating original data.